牛叉诊股

[{"date":"2026.05.20","stock":"-4.00","trade":"-0.82","ind":"0.00"},{"date":"2026.05.19","stock":"2.69","trade":"0.76","ind":"0.26"},{"date":"2026.05.18","stock":"1.65","trade":"-1.13","ind":"-0.20"},{"date":"2026.05.15","stock":"-4.60","trade":"-0.86","ind":"-1.17"},{"date":"2026.05.14","stock":"-4.92","trade":"-2.00","ind":"-2.14"},{"date":"2026.05.13","stock":"9.21","trade":"-0.69","ind":"1.67"},{"date":"2026.05.12","stock":"-2.97","trade":"-1.53","ind":"-0.47"},{"date":"2026.05.11","stock":"-2.61","trade":"3.08","ind":"2.16"},{"date":"2026.05.08","stock":"-7.99","trade":"0.41","ind":"-0.50"},{"date":"2026.05.07","stock":"4.95","trade":"0.68","ind":"1.18"},{"date":"2026.05.06","stock":"3.21","trade":"-0.25","ind":"2.33"},{"date":"2026.04.30","stock":"-2.87","trade":"-0.48","ind":"-0.09"},{"date":"2026.04.29","stock":"4.41","trade":"-0.20","ind":"1.96"},{"date":"2026.04.28","stock":"-5.34","trade":"-0.90","ind":"-1.10"},{"date":"2026.04.27","stock":"-6.32","trade":"-0.12","ind":"0.37"},{"date":"2026.04.24","stock":"-0.11","trade":"-1.02","ind":"-0.69"},{"date":"2026.04.23","stock":"3.09","trade":"-2.31","ind":"-0.88"},{"date":"2026.04.22","stock":"1.21","trade":"1.01","ind":"1.30"},{"date":"2026.04.21","stock":"-5.26","trade":"-1.07","ind":"0.10"},{"date":"2026.04.20","stock":"2.42","trade":"-0.70","ind":"0.55"},{"date":"2026.04.17","stock":"-0.98","trade":"-1.25","ind":"0.60"}]

万泽股份,深证成指,生物制品指数

压力支撑

该股压力位为37.19元，支撑位为35.99元。

[{"text":"\u538b\u529b\u4f4d","value":"37.19","date":1779206400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"35.99","date":1779206400,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.3资金面打败了61%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：05月20日 20:30

机构今日流向(万元)	-1661.43	机构5日流向(万元)	-9799.78
机构10日流向(万元)	-14388.46	机构20日流向(万元)	-28456.91

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加4962.50万股，其中基金净减仓10家，主力净增仓90家，请投资者中长期谨慎为宜。

截止2025-12-31，共235家主力机构（一般法人7家，基金226家，社保基金2家），持仓量总计30084.27万股，占流通A股60.17%
其中，基金持仓与2025-06-30相比：
增仓：17家，增持 420.19万股
减仓：27家，减持 1299.27万股
新出现在主力名单中：184家，持有12733.13万股
从主力名单中消失：94家，原持有7410.62万股

消息面诊股

诊断结果：5.1消息面打败了9%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

利空	重大事项	公司违规：处罚类型	2026-04-30
一般消息	分红转增	不分配不转增	2026-04-21
一般消息	重大事项	关联交易	2026-04-21
一般消息	重大事项	公司股东股份解押	2026-04-04
一般消息	募资投向	公司出售资产	2026-03-27
一般消息	重大事项	公司股东股份解押	2026-01-21
一般消息	股东大会	临时股东大会	2025-12-16
一般消息	高管变动	不再担任	2025-12-08
一般消息	高管变动	取消监事会	2025-10-29
一般消息	分红转增	不分配不转增	2025-08-23
一般消息	重大事项	公司股东股份解押	2025-06-03

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	1条	0条	1条

行业面诊股

诊断结果：5.3行业面打败了79%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑输大盘。

[{"date":"2026.05.20","price":"0.00","value":"-0.82"},{"date":"2026.05.19","price":"0.26","value":"0.76"},{"date":"2026.05.18","price":"-0.20","value":"-1.13"},{"date":"2026.05.15","price":"-1.17","value":"-0.86"},{"date":"2026.05.14","price":"-2.14","value":"-2.00"},{"date":"2026.05.13","price":"1.67","value":"-0.69"},{"date":"2026.05.12","price":"-0.47","value":"-1.53"},{"date":"2026.05.11","price":"2.16","value":"3.08"},{"date":"2026.05.08","price":"-0.50","value":"0.41"},{"date":"2026.05.07","price":"1.18","value":"0.68"},{"date":"2026.05.06","price":"2.33","value":"-0.25"},{"date":"2026.04.30","price":"-0.09","value":"-0.48"},{"date":"2026.04.29","price":"1.96","value":"-0.20"},{"date":"2026.04.28","price":"-1.10","value":"-0.90"},{"date":"2026.04.27","price":"0.37","value":"-0.12"},{"date":"2026.04.24","price":"-0.69","value":"-1.02"},{"date":"2026.04.23","price":"-0.88","value":"-2.31"},{"date":"2026.04.22","price":"1.30","value":"1.01"},{"date":"2026.04.21","price":"0.10","value":"-1.07"},{"date":"2026.04.20","price":"0.55","value":"-0.70"},{"date":"2026.04.17","price":"0.60","value":"-1.25"}]

深证成指,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	欧林生物	34.51%	-0.84%	6.2分
2	*ST双成	29.18%	6.60%	6.3分
3	赛伦生物	17.39%	9.60%	6.0分
4	金迪克	15.24%	4.95%	5.3分
5	沃森生物	12.52%	-5.78%	5.8分
6	昊帆生物	12.13%	11.68%	6.4分
7	诺唯赞	10.34%	2.51%	6.5分
8	四环生物	8.95%	11.44%	6.4分
9	优宁维	0.49%	-3.34%	5.2分
10	-	0.40%	-8.12%	分
11	东宝生物	0.38%	-2.56%	4.1分
12	华兰疫苗	0.15%	-4.59%	5.4分
13	康泰生物	-1.78%	-7.06%	4.0分
14	西藏药业	-2.05%	-4.27%	5.4分
15	百克生物	-2.27%	-5.85%	4.4分
16	辽宁成大	-3.60%	-4.98%	4.4分
17	卫光生物	-4.38%	0.42%	5.1分
18	智飞生物	-4.72%	-5.51%	3.5分
19	成大生物	-5.74%	-3.81%	4.0分
20	智翔金泰	-6.04%	-5.19%	4.1分
21	上海莱士	-6.14%	-4.63%	4.0分
22	长春高新	-6.41%	-6.98%	3.9分
23	近岸蛋白	-6.49%	-8.70%	4.6分
24	神州细胞	-6.58%	-3.34%	4.8分
25	博晖创新	-7.54%	-5.56%	4.1分
26	-	-7.56%	-5.14%	分
27	康辰药业	-7.67%	-1.71%	5.5分
28	华兰生物	-7.78%	-4.15%	3.9分
29	义翘神州	-8.55%	-4.51%	4.1分
30	百普赛斯	-8.55%	0.50%	4.5分
31	特宝生物	-10.37%	-2.03%	6.1分
32	康华生物	-10.68%	-7.49%	3.9分
33	我武生物	-11.02%	-4.65%	4.0分
34	康希诺	-11.90%	-1.05%	5.1分
35	天坛生物	-12.98%	-6.71%	4.2分
36	君实生物	-14.52%	-4.30%	5.1分
37	迈威生物	-14.57%	-5.91%	4.0分
38	禾元生物	-14.64%	-9.26%	5.8分
39	万泽股份	-14.98%	-9.10%	5.1分
40	百奥泰	-15.02%	-2.39%	5.1分
41	甘李药业	-15.35%	-5.40%	4.5分
42	通化东宝	-15.47%	-5.09%	4.6分
43	安科生物	-15.81%	-6.84%	4.1分
44	博雅生物	-16.46%	-8.30%	3.8分
45	艾迪药业	-17.51%	-5.39%	4.5分
46	康弘药业	-18.63%	-6.27%	3.7分
47	派林生物	-18.67%	-10.33%	3.8分
48	赛升药业	-19.11%	-8.18%	3.6分
49	诺诚健华	-20.49%	-8.00%	4.1分
50	科兴制药	-22.05%	-5.00%	5.8分
51	荣昌生物	-22.28%	-2.01%	5.0分
52	三生国健	-25.98%	-8.74%	4.9分
53	*ST未名	-36.60%	-11.97%	4.4分
54	-	-48.73%	-12.90%	分

<上一页 1 2 3 4 5...9 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
海通证券	2012-09-11	增持	增持
山西证券	2012-09-11	增持	增持
国信证券	2012-09-11	买入	买入
长江证券	2012-09-11	增持	增持
长城证券	2012-09-10	买入	买入

基本面诊股

诊断结果：6.8基本面打败了81%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：弱（60分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：很强，居行业前列，两项指标的行业排名分别为 3/70 ， 26/70。

[{"date":"2026-03-31","value":"4.67","vol":"-2.96"},{"date":"2025-12-31","value":"13.29","vol":"-8.40"},{"date":"2025-09-30","value":"11.61","vol":"-10.09"},{"date":"2025-06-30","value":"8.36","vol":"-0.67"},{"date":"2025-03-31","value":"5.10","vol":"0.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	4.67	13.29	11.61	8.36	5.10
行业(%)	-2.96	-8.40	-10.09	-0.67	0.44

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"71.11","vol":"61.64"},{"date":"2025-12-31","value":"71.75","vol":"66.98"},{"date":"2025-09-30","value":"73.61","vol":"67.71"},{"date":"2025-06-30","value":"73.07","vol":"67.98"},{"date":"2025-03-31","value":"75.49","vol":"69.02"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	71.11	71.75	73.61	73.07	75.49
行业(%)	61.64	66.98	67.71	67.98	69.02

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：一般，低于行业平均，两项指标的行业排名分别为 25/70 ， 22/70。

[{"date":"2026-03-31","value":"7.39","vol":"16.15"},{"date":"2025-12-31","value":"19.62","vol":"35.93"},{"date":"2025-09-30","value":"21.00","vol":"45.81"},{"date":"2025-06-30","value":"24.40","vol":"7037.48"},{"date":"2025-03-31","value":"15.34","vol":"6245.21"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	7.39	19.62	21.00	24.40	15.34
行业(%)	16.15	35.93	45.81	7037.48	6245.21

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"6.58","vol":"74.78"},{"date":"2025-12-31","value":"2.22","vol":"34.78"},{"date":"2025-09-30","value":"22.45","vol":"45.67"},{"date":"2025-06-30","value":"21.84","vol":"5.32"},{"date":"2025-03-31","value":"10.52","vol":"-8.96"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	6.58	2.22	22.45	21.84	10.52
行业(%)	74.78	34.78	45.67	5.32	-8.96

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，两项指标的行业排名分别为 21/70 ， 25/70。

[{"date":"2026-03-31","value":"0.07","vol":"0.06"},{"date":"2025-12-31","value":"0.30","vol":"0.30"},{"date":"2025-09-30","value":"0.23","vol":"0.21"},{"date":"2025-06-30","value":"0.15","vol":"0.14"},{"date":"2025-03-31","value":"0.08","vol":"0.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.07	0.30	0.23	0.15	0.08
行业(次)	0.06	0.30	0.21	0.14	0.06

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.22","vol":"0.29"},{"date":"2025-12-31","value":"0.91","vol":"1.30"},{"date":"2025-09-30","value":"0.63","vol":"0.90"},{"date":"2025-06-30","value":"0.45","vol":"0.56"},{"date":"2025-03-31","value":"0.23","vol":"0.26"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.22	0.91	0.63	0.45	0.23
行业(次)	0.29	1.30	0.90	0.56	0.26

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"-7.45","vol":"-71.66"},{"date":"2025-12-31","value":"27.62","vol":"12.85"},{"date":"2025-09-30","value":"3.31","vol":"0.21"},{"date":"2025-06-30","value":"10.41","vol":"-1404.66"},{"date":"2025-03-31","value":"-7.17","vol":"-47.97"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	-7.45	27.62	3.31	10.41	-7.17
行业	-71.66	12.85	0.21	-1404.66	-47.97

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"3.55","vol":"1.77"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"5.07","vol":"1.58"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	3.55	-	5.07	-
行业	0.00	1.77	0.00	1.58	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 4/70 ， 3/70。

[{"date":"2026-03-31","value":"1.61","vol":"6.75"},{"date":"2025-12-31","value":"1.06","vol":"5.88"},{"date":"2025-09-30","value":"1.34","vol":"6.07"},{"date":"2025-06-30","value":"1.28","vol":"6.70"},{"date":"2025-03-31","value":"1.37","vol":"7.82"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	1.61	1.06	1.34	1.28	1.37
行业	6.75	5.88	6.07	6.70	7.82

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.18","vol":"5.22"},{"date":"2025-12-31","value":"0.66","vol":"4.49"},{"date":"2025-09-30","value":"0.82","vol":"4.89"},{"date":"2025-06-30","value":"0.78","vol":"5.34"},{"date":"2025-03-31","value":"0.88","vol":"6.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	1.18	0.66	0.82	0.78	0.88
行业	5.22	4.49	4.89	5.34	6.40

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 10/70 ， 4/70。

[{"date":"2026-03-31","value":"64.38","vol":"27.44"},{"date":"2025-12-31","value":"61.47","vol":"27.58"},{"date":"2025-09-30","value":"60.01","vol":"28.02"},{"date":"2025-06-30","value":"59.38","vol":"26.70"},{"date":"2025-03-31","value":"58.89","vol":"26.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	64.38	61.47	60.01	59.38	58.89
行业(%)	27.44	27.58	28.02	26.70	26.06

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"2.02","vol":"1.46"},{"date":"2025-12-31","value":"1.76","vol":"1.28"},{"date":"2025-09-30","value":"1.67","vol":"0.58"},{"date":"2025-06-30","value":"1.64","vol":"1.13"},{"date":"2025-03-31","value":"1.61","vol":"0.79"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	2.02	1.76	1.67	1.64	1.61
行业(%)	1.46	1.28	0.58	1.13	0.79

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
兴业证券	2026-04-30	增持
国盛证券	2026-04-28	买入
国海证券	2026-04-27	买入
华创证券	2026-04-21	增持	增持
中信建投证券	2026-03-24	买入	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"1.02","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.77","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.93","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.97","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"3.34","blueLineValue":"0.66","type":"YC"}]

[万泽股份]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]